Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 3, 1999, Pages 451-460

  Carraway, Joseph W ^a   Park, Sonhee ^a   McCune, Sylvia A ^a   Holycross, Bethany J ^a   Radin, M Judith ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b Department of Veterinary Biosciences ^*  (United States)

Author keywords

Angiotensin II subtype 1 receptor antagonist; Angiotensin converting enzyme inhibitors; Atrial natriuretic peptide; Cardiac hypertrophy; Hypertension; SHHF Mcc fa(cp) rat

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; MESSENGER RNA; MYOSIN; PLACEBO; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HORMONE DETERMINATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ATRIAL NATRIURETIC FACTOR; BIPHENYL COMPOUNDS; BLOOD PRESSURE; BODY WEIGHT; CAPTOPRIL; CARDIOMEGALY; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; ISOENZYMES; MALE; MYOSIN HEAVY CHAINS; ORGAN SIZE; RATS; RATS, INBRED STRAINS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENIN; RNA, MESSENGER; SYSTOLE; TETRAZOLES;

EID: 0033023437     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199903000-00016     Document Type: Article

References (39)

1. Mancia G. Angiotensin-converting enzyme inhibitors in the treatment of hypertension. J Cardiovasc Pharmacol 1991;18(suppl 7):S1-3.
2. Cleland JGF, Morgan K. Inhibition of the renin-angiotensin-aldosterone system in heart failure: new insights from basic clinical research. Curr Opin Cardiol 1996;11:252-62.
3. Awan NA, Mason DT. Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure. Am Heart J 1996;131:177-85.
4. Rush JE, Rajfer SI. Theoretical basis for the use of angiotensin II antagonist in the treatment of heart failure. J Hypertens 1993;11(suppl 3):S69-71.
5. Burnier M, Waeber B, Brunner HR. The advantages of angiotensin II antagonism. J Hypertens 1994;12(suppl 2):S7-15.
6. Brooks WW, Bing OH, Conrad CH, et al. Captopril modifies gene expression in hypertrophied and failing hearts of aged spontaneous hypertensive rats. Hypertension 1997;30:1362-8.
7. Taylor K, Patten RD, Smith JJ, et al. Divergent effects of angiotensin converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats. J Cardiovasc Pharmacol 1998;31:654-60.
8. cp rat model: effects of gender and genotype on age of expression of metabolic complications and congestive heart failure and on response to drug therapy. In: Shafrir E, ed. Lessons from animal diabetes V. London: Smith-Gordon, 1996:255-70.
9. cp) rats. Am J Physiol 1997;273:H228-33.
10. Haas GJ, McCune S, Brown DM, Cody RJ. Reversal of myocardial hypertrophy in a rodent model of heart failure. Circulation 1990;82(suppl III):675.
11. Radin MJ, Jenkins JE, McCune SA, Hamlin R. Effects of enalapril and clonidine on glomerular structure, function, and atrial natriuretic peptide receptors in SHHF/Mcc-cp rats. J Cardiovasc Pharmacol 1992;19:464-72.
12. cp rats with antihypertensive drugs, nifedipine and enalapril: effects on body weight, fat distribution, insulin resistance, and systolic pressure. Obesity Res 1993;1:433-42.
13. 1 subtype angiotensin II receptor antagonist. J Pharmacol Exp Ther 1993;265:826-34.
14. 1 receptor antagonist in hypertension. Hypertension 1995;25:22-9.
15. Bradford MM. A rapid and sensitive method for the quantisation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
16. Bergmeyer HU, Bernt E, Schmidt F, Stock H. D-Glucose determination with hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, ed. Methods of enzymatic analysis, 2nd ed. Vol 3. Deerfield Beach, FL: Verlag Chemie International, 1974;1196-201.
17. Sambrook J, Fristsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Vol 1. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989:4-5-8 and 2-24-30.
18. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A 1984;81(7):1991-5.
19. Hoh JF, McGrath PA, Hale PT. Electrophoretic analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. J Mol Cell Cardiol 1978;10(11):1053-76.
20. Poulter NR. Beyond blood pressure. J Hum Hypertens 1994;8(suppl 1):S3-8.
21. Gambardella S, Frontoni S, Pellegrinotti M, Testa G, Spallone V, Menzinger G. Carbohydrate metabolism in hypertension: influence of treatment. J Cardiovasc Pharmacol 1993;22(suppl 6):S87-97.
22. Donnelly R. Angiotensin-converting enzyme inhibitors and insulin sensitivity: metabolic effects in hypertension, diabetes, and heart failure. J Cardiovasc Pharmacol 1992;20(suppl 11):S38-44.
23. 1 receptors. Eur J Pharmacol 1995;282:77-86.
24. Moan A, Hoieggen A, Seljeflot I, Risanger T, Arnesen H, Kjeldsen SE. The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity. J Hypertens 1996;14:1093-7.
25. Wallmyer K, Wann S, Sagar KB, Kalbfleisch J, Klopfenstein HS. The influence of preload and heart rate on Doppler echocardiographic indexes of left ventricular performance: comparison with invasive indexes in an experimental preparation. Circulation 1986;74:181-6.
26. cp rats (1994 Ab). FASEB J 1996;10:A345.
27. Hartley CJ, Michael LH, Entman ML. Noninvasive measurement of ascending aortic blood velocity in mice. Am J Physiol 1995;268:H499-505.
28. Hoit BD, Khoury SF, Kranias EG, Ball N, Walsh RA. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res 1995;77:632-7.
29. Taffet GE, Hartley CJ, Wen X, Pham T, Michael LH, Entman ML. Noninvasive indexes of cardiac systolic and diastolic function in the hyperthyroid and senescent mouse. Am J Physiol 1996;270:H2204-9.
30. Gomez AM, Valdivia H, Cheng H, et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997;276:800-6.
31. Buttrick PM, Kaplan M, Leinwand LA, Scheuer J. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J Mol Cell Cordiol 1994;26:61-7.
32. Morano I, Adler K, Weismann K, Knorr A, Erdmann E, Bohm M. Correlation of myosin heavy chain expression in the rat with cAMP in different models of hypertension-induced cardiac hypertrophy. J Mol Cell Cardiol 1993;25:387-94.
33. Sen S, Young D. Effect of antihypertensive therapy upon myosin isozyme distribution in spontaneously hypertensive rats. J Hypertens 1992;10:749-56.
34. Ling Q, Guo ZG, Su Z, Guo X. Regression of cardiac hypertrophy and myosin isoenzyme patterns by losartan and captopril in renovascular hypertensive rats. Acta Pharmacol Sinica 1994;15(3):206-10.
35. Younes A, Boluyt MO, O'Neill L, Meredith AL, Crow MR, Lakatta EG. Age-associated increase in rat ventricular ANP gene expression correlates with cardiac hypertrophy. Am J Physiol 1995;269:H1003-8.
36. McKenzie JC, Kelly KB, Merisko-Liversidge ME, Kennedy J, Klein RM. Developmental pattern of ventricular atrial natriuretic peptide (ANP) expression in chronically hypoxic rats as an indicator of the hypertrophic process. J Mol Cell Cardiol 1994;26:753-67.
37. Kinnunem P, Vuolteenaho P, Usima P, Ruskoaho H. Passive mechanical stretch releases atrial natriuretic peptide from rat ventricular myocardium. Circ Res 1992;70:1244-53.
38. Thibault G, Nemer M, Drouin J, et al. Ventricles as a major site of atrial natriuretic factor synthesis in cardiomyopathic hamsters with heart failure. Circ Res 1989;65:71-82.
39. Abassi ZA, Kelly G, Golomb E, Klein H, Keiser HR. Losartan improves the natriuretic response to ANF in rats with high-output heart failure. J Pharmacol Exp Ther 1994;268:224-30.